Claims for Patent: 8,431,597

Summary for Patent: 8,431,597

Title:	Benzimidazole derivatives
Abstract:	The present invention relates to a compound of the Formula I ##STR00001## or a pharmaceutically acceptable salt thereof, wherein R.sup.1, R.sup.2, R.sup.3A, R.sup.3B, R.sup.4, R.sup.5, X, m, and n are as defined herein. Such novel benzamidazole derivatives are useful in the treatment of abnormal cell growth, such as cancer, in mammals. This invention also relates to a method of using such compounds in the treatment of abnormal cell growth in mammals, especially humans, and to pharmaceutical compositions containing such compounds.
Inventor(s):	Munchhof; Michael J. (Salem, CT), Reiter; Lawrence A. (Mystic, CT), La Greca; Susan D. (Old Lyme, CT), Jones; Christopher S. (Gales Ferry, CT), Li; Qifang (Stonington, CT)
Assignee:	Pfizer Inc. (New York, NY)
Application Number:	13/404,169
Patent Claims:	1. A pharmaceutical composition, comprising a compound which is ##STR00198## or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier or excipient.